Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 1;63(6):486-490.
doi: 10.3760/cma.j.cn112139-20250115-00028.

[Current treatment status and future perspectives of advanced gallbladder cancer]

[Article in Chinese]
Affiliations
Review

[Current treatment status and future perspectives of advanced gallbladder cancer]

[Article in Chinese]
S T He et al. Zhonghua Wai Ke Za Zhi. .

Abstract

Gallbladder cancer has an insidious onset,and most of the cases are in advanced stage at the time of diagnosis,with unfavorable prognosis. Radical surgery is the only potential curative method for gallbladder cancer at present,but radical surgery of advanced gallbladder cancer is difficult and the postoperative recurrence rate is high. Neoadjuvant therapy and conversion therapeutic modalities are of great significance to improve the rate of radical resection of advanced gallbladder cancer and reducing the risk of postoperative recurrence. The application and research of minimally invasive approach surgery in gallbladder cancer are increasing; organoid technology provides a new platform for precise and individualized treatment and new drug development, and the application of artificial intelligence combined with big data shows great potential in tumor diagnosis, surgical assistance and prognosis evaluation. Although these techniques provide more means to improve the therapeutic effect of advanced gallbladder cancer, there are still challenges in clinical practice and more high-quality clinical studies.

胆囊癌发病隐匿,多数病例确诊时已处于进展期,预后不佳。根治性手术是目前唯一可能治愈胆囊癌的方法,但进展期胆囊癌根治性切除难度大,术后复发率高。新辅助治疗和转化治疗模式对提高进展期胆囊癌的R0切除率和降低术后复发风险具有重要意义。微创入路手术在胆囊癌中的应用和研究逐渐增多;类器官技术为精准化、个体化治疗和新药研发提供了新的平台;人工智能结合大数据的应用在肿瘤的诊断、手术辅助和预后评估中展现出巨大潜力。尽管这些技术为提升进展期胆囊癌的治疗效果提供了更多手段,但在临床实践中仍面临挑战,仍需更多高质量临床研究结果予以验证。.

PubMed Disclaimer